JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Butler, T. C.
Right arrow Articles by Waddell, W. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Butler, T. C.
Right arrow Articles by Waddell, W. J.
Journal of Pharmacology And Experimental Therapeutics, Vol. 111, Issue 4, 425-435, 1954
Copyright © 1954 by American Society for Pharmacology and Experimental Therapeutics


PHENOBARBITAL: STUDIES OF ELIMINATION, ACCUMULATION, TOLERANCE, AND DOSAGE SCHEDULES

Thomas C. Butler 1, Collins Mahaffee 1, and William J. Waddell 1

1 Department of Pharmacology, University of North Carolina School of Medicine, Chapel Hill, North Carolina

An ultraviolet spectrophotometric method is described for the determination of phenobarbital in plasma. This method has been applied to several problems pertaining to the clinical use of the drug.

In eleven human subjects the proportion of phenobarbital eliminated from the plasma in the course of one day was found to lie within the limits of 11 and 23 per cent.

Administration of phenobarbital at daily intervals or more frequently leads to accumulation.

Both in man and in the dog the effects associated with a given plasma concentration of phenobarbital diminish over the course of the first few days of administration. Tolerance to the hypnotic effects in man more than keeps pace with accumulation and completely obscures any clinical evidence of accumulation.

In chronic dosage schedules in man, one dose of phenobarbital daily results in only small proportional fluctuations of plasma concentration during the day. It is dubious whether there is any practical advantage in giving the drug in more than one dose daily or in forms in which it is released gradually.

Submitted on March 23, 1954




This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
P. J. Murphy
The Development of Drug Metabolism Research as Expressed in the Publications of ASPET: Part 1, 1909-1958
Drug Metab. Dispos., January 1, 2008; 36(1): 1 - 5.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
S.R. Snodgrass and B. R. Parks
Anticonvulsant Blood Levels: Historical Review With a Pediatric Focus
J Child Neurol, November 1, 2000; 15(11): 734 - 746.
[Abstract] [PDF]


Home page
Hum Exp ToxicolHome page
A.H. Stead, W. Hook, A.C. Moffat, and D. Berry
Therapeutic, Toxic and Fatal Blood Concentration Ranges of Antiepileptic Drugs as an Aid to the Interpretation of Analytical Data
Human and Experimental Toxicology, January 1, 1983; 2(1): 135 - 147.
[Abstract] [PDF]


Home page
Hum Exp ToxicolHome page
A.H. Stead and A.C. Moffat
A Collection of Therapeutic, Toxic and Fatal Blood Drug Concentrations in Man
Human and Experimental Toxicology, January 1, 1983; 2(3): 437 - 464.
[Abstract] [PDF]


Home page
ScienceHome page
D. E. McMillan, L. S. Harris, J. M. Frankenheim, and J. S. Kennedy
l-Dgr9-trans-Tetrahydrocannabinol in Pigeons: Tolerance to the Behavioral Effects
Science, July 31, 1970; 169(3944): 501 - 503.
[Abstract] [PDF]


Home page
Arch OphthalmolHome page
J. E. HARRIS
PHARMACOLOGY AND TOXICOLOGY
Arch Ophthalmol, August 1, 1955; 54(2): 262 - 299.
[PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1954 by the American Society for Pharmacology and Experimental Therapeutics.